Biotech firms raised $1.8 billion in Q3 venture funding

11/4/2011 | MassDevice.com (Boston)

Life sciences firms secured $1.8 billion in venture capital investments during the third quarter with 170 deals, an 18% drop from the second quarter, according to a PricewaterhouseCoopers report. Tracy Lefteroff of PwC US pointed to regulatory challenges, difficulty with IPOs and equity market volatility as reasons.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI